1295998

Lixin Zhang, M.D. — FEI 3041257710

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 19, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Amherst, NY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance